- Home
- KROS vs IHRT Comparison
KROS vs IHRT Comparison
Compare KROS & IHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KROS | IHRT |
|---|---|---|
| Founded | 2015 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Broadcasting |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 655.9M | 552.6M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | KROS | IHRT |
|---|---|---|
| Price | $19.22 | $3.65 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 3 |
| Target Price | ★ $23.00 | $4.33 |
| AVG Volume (30 Days) | 365.3K | ★ 500.5K |
| Earning Date | 02-25-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.57 | N/A |
| Revenue | $246,718,000.00 | ★ $3,856,033,000.00 |
| Revenue This Year | $6,924.79 | $1.98 |
| Revenue Next Year | N/A | $5.65 |
| P/E Ratio | $12.19 | ★ N/A |
| Revenue Growth | ★ 37798.31 | 1.39 |
| 52 Week Low | $9.12 | $0.95 |
| 52 Week High | $22.55 | $5.44 |
Technical Indicators
Market Signals| Indicator | KROS | IHRT |
|---|---|---|
| Relative Strength Index (RSI) | 49.60 | 39.08 |
| Support Level | $18.33 | $3.63 |
| Resistance Level | $19.67 | $4.00 |
| Average True Range (ATR) | 0.70 | 0.19 |
| MACD | -0.03 | -0.04 |
| Stochastic Oscillator | 70.37 | 8.03 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About IHRT iHeartMedia Inc.
iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.